Fetal Macrocephaly: Prenatal Findings and Follow‐Up in Cases With High Risk for Abnormal Outcome
Prenatal Diagnosis · 2026
DOI: 10.1002/pd.70049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, 2026. Verfasst von Hadas Miremberg und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Obstetric Ultrasound, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Megalencephaly. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
Fetal macrocephaly (HC Z ‐score ≥ +2) is a common reason for referral for neurosonography. While most cases are benign and asymptomatic, syndromic macrocephaly poses a significant risk of abnormal neurodevelopment. This study aimed to describe the sonographic and genetic features of fetuses at the highest risk of syndromic macrocephaly.
Methods
We retrospectively analyzed 19 fetuses with either HC Z ‐scores ≥ +2.5 or those with ≥ +2 and associated anomalies, evaluated between January 2015 and October 2024. Assessments included fetal neurosonography, anomaly scans, MRI, and genetic work‐up. Outcomes and postnatal/postmortem data were reviewed.
Results
Mean gestational age at the time of diagnosis was 29.6 weeks (range 23–35.4 weeks). Seventeen fetuses (89%) had associated anomalies: large for gestational age (12/19), callosal abnormalities (11/19), malformation of cortical development (13/19), and facial dysmorphism (11/19) were diagnosed. Genetic investigation results (CMA) were available for 17 of the 19 patients. Overall, 14 of the 17 patients had abnormal genetic findings, mostly involving mTOR pathway genes .
Conclusion
High Z ‐scores and additional imaging findings strongly correlate with genetic abnormalities, most often mTOR‐related. These results support the integration of exome sequencing into prenatal evaluation of fetal macrocephaly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Obstetric Ultrasound, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
- Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Department of Pathology, Meir Medical Center, Kfar Saba, Israel.
- Genetics Institute & Genome Center, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
- Maccabi Genetic Institute & Bioinformatics Unit, Sheba Cancer Research Center, Ramat Gan, Israel.
- Pediatric Radiology Unit, Dana Children Hospital Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
ORCID-Profile: Gustavo Malinger, Michal Levy, Yuval Yaron
Zitieren
APA
Miremberg, H., Malinger, G., Kidron, D., Levy, M., Yaron, Y., Shohat, M., Goldstein, R., Ben Sira, L., Brusilov, M., Birnbaum, R., & Haratz, K. K. (2026). Fetal Macrocephaly: Prenatal Findings and Follow‐Up in Cases With High Risk for Abnormal Outcome. Prenatal Diagnosis. https://doi.org/10.1002/pd.70049
Vancouver
Miremberg H, Malinger G, Kidron D, Levy M, Yaron Y, Shohat M, et al. Fetal Macrocephaly: Prenatal Findings and Follow‐Up in Cases With High Risk for Abnormal Outcome. Prenatal Diagnosis. 2026. doi:10.1002/pd.70049
BibTeX
@article{Miremberg2026,
author = {Miremberg, Hadas and Malinger, Gustavo and Kidron, Deborah and Levy, Michal and Yaron, Yuval and Shohat, Mordechai and Goldstein, Rayna and Ben Sira, Liat and Brusilov, Michael and Birnbaum, Roee and Haratz, Karina Krajden},
title = {Fetal Macrocephaly: Prenatal Findings and Follow‐Up in Cases With High Risk for Abnormal Outcome},
journal = {Prenatal Diagnosis},
year = {2026},
doi = {10.1002/pd.70049}
}
EUVIMED